Although the role of PARP-1 in human AD is not fully elucidated and many mechanisms are under investigations, accumulating evidences suggest that PARP-1 inhibitors are viable to neuroprotection and PARP-1 has emerged as a potential therapeutic target for AD12,.13 The gene discussed is PARP1; the disease is Alzheimer disease.